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Potassium bicarbonate, but not sodium bicarbonate, reduces
urinary calcium excretion and improves calcium balance in
healthy men
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Departments of Medicine and Biochemistry, and the Clinical Research Center, Medical College of Wisconsin, Froedtert Memorial Lutheran
Hospital, 9200 West Wisconsin Avenue, Milwaukee, Wisconsin, USA
Potassium bicarbonate, but not sodium bicarbonate, reduces urinary
calcium excretion and improves calcium balance in healthy men. Previous
studies demonstrated that the administration of NaHCO3 or sodium
citrate had either only a small effect to reduce urinary Ca excretion or
no effect, but that potassium citrate significantly reduced urinary Ca
excretion. In order to further evaluate and compare the effects of
NaHCO3 and of KHCO3, we performed ten metabolic balances in
healthy men during 18 control days, 12 days of NaHCO3. 60 mmol/day
and 12 days of KHCO3, 60 mmol/day. Six subjects were fed a low Ca
diet (5.2 0.7 SD mmol/day) and three of these were also given
calcitriol (0.5 sg 6-hourly). Four subjects ate a normal Ca diet (19.5
1.3 mmol/day). For all 10 subjects, KHCO3 administration reduced
urinary Ca excretion from control by —0.9 0.7 mmol/day, P < 0.001.
Net intestinal Ca absorption did not change detectably so that Ca
balances became less negative by a +0.9 0.9 mmol/day; P = 0.01.
KHCO3 administration was also accompanied by more positive P04 and
Mg balances. NaHCO3 administration had no significant effect on
urinary Ca excretion or Ca balance. NaHCO3 and KHCO3 administra-
tion were accompanied by equivalently more positive Na or K bal-
ances, respectively and equivalently more negative acid balances
(HCO3 retention). Neither NaHC0 or KHCO3 altered fasting serum
HCO3 concentrations, blood pH, serum 1 ,25-(OH)rD or PTH concen-
trations. We conclude that KHCO3 promotes more positive Ca balances
by either enhancing renal Ca retention or skeletal Ca retention or both.
The effects of alterations in acid-base balance on urinary
calcium excretion and calcium balance have not been com-
pletely defined. Metabolic acidosis and increased acid produc-
tion, exemplified by the administration of ammonium chloride,
or increased dietary protein intake, are well known to be
accompanied by augmented urinary calcium excretion [1—6] as
a consequence of inhibition of net renal tubular calcium reab-
sorption [31, lack of compensatory augmentation of intestinal
calcium absorption [7], stimulation of bone resorption [2, 6, 8—
10] and thus negative calcium balances [2, 7]. By contrast, the
administration of NaHCO3 is accompanied by only small reduc-
tions in urinary calcium excretion [7], although NaHCO3 does
ablate the increase in urinary calcium excretion and more
negative calcium balances that occurred when acid production
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was increased by increasing dietary protein intake [11]. More
recently, Sakhaee and associates observed that the administra-
tion of sodium citrate, 60 mEq/day to five patients with uric acid
nephrolithiasis, failed to reduce urinary calcium excretion sig-
nificantly, whereas the administration of equivalent quantities
of potassium citrate was accompanied by a significant decline in
urinary calcium excretion [12]. The present studies were,
therefore, undertaken to further evaluate and compare the
effects of NaHCO3 and KHCO1 on the components of calcium
balance in healthy men.
Methods
Ten metabolic balance studies were performed in nine
healthy men ranging in age from 23 to 46 years. They were
studied in the Medical College of Wisconsin Clinical Research
Center with their consent, under a protocol approved by the
Medical College of Wisconsin Human Research Review Com-
mittee. Each subject ate two constant diets on alternate days
that were of comparable composition during 18 control days, 12
days of NaHCO3, 20 mEq t.i.d. with meals and 12 days of
KHCO3, 20 mEq t.i.d. with meals. The salts were administered
as a solution providing 20 mEq in a volume of 30 ml. The
subjects rinsed the containers with deionized water and drank
the rinses to insure complete ingestion of each dose. Four
subjects received NaHCO3 first and then KHCO3 while in six
subjects the salts were administered in the opposite sequence.
The subjects drank deionized water ad libitim. Six studies were
performed while the subjects were fed a low calcium diet
providing an average of 5.2 0.7 SD mmol Ca/day. During three
of these studies the subjects were also given calcitriol, 0.5 .g
6-hourly, to further stimulate net bone resorption [13]. Four
studies were performed while the subjects were fed diets
providing normal quantities of calcium averaging 19.5 1.3
mmol/day. One of the subjects was studied twice, once while he
ate a low calcium diet and was given calcitriol, and once while
he ate a normal calcium diet.
To improve the precision of estimates of fecal mineral excre-
tion rates and to document the steady state, each subject was
continuously fed 30 radio-opaque pellets/day, 10 with each
meal, to monitor the accuracy of timing of fecal collections and
of fecal recovery [14, 15]. The pellets were administered in 5 g
of apple sauce with each meal in order to avoid aspiration. We
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Fig. 1. The use of orally administered radio-opaque pellets to monitor
recovery offeces. A. Mean pellet retention at the end of each study day
for all ten studies during control and each of the two subsequent periods
of bicarbonate administration SEM. Pellets of different shapes were
fed during control, during HCO3 I and during HCO3 II. B. Mean
cumulative pellet excretion in comparison to cumulative pellet admin-
istration (solid line) during control and during the two subsequent
periods of HCO3 administration SD.
did not want to place the pellets in gelatin capsules because of
the effect of gelatin to augment urinary hydroxyproline excre-
tion, an index of bone resorption. Pellets of different shapes
were used during the control period and each of the two
experimental periods of bicarbonate administration to enable
detection of the new steady states. Stools were collected
individually, frozen, weighed and radiographs obtained. The
pellets in each stool were counted independently by three
observers and the largest number taken as the number in that
stool. The stools of two to four days were pooled for analysis.
Figure 1 documents the use of the radio-opaque pellets. Mean
pellet retention at the end of each study day is shown in Figure
lÀ. Pellet retention reached a steady state by day 6, 24 and 36,
the sixth days of the three experimental phases of the balances.
For each subject the steady-state intestinal pellet pool was
calculated by non-linear regression using the time of each
change by ingestion or excretion: Pellets retained at time t =
steady-state pool size x (le_kt) [16]. The calculated steady
state intestinal pellet pool ranged from 37 to 80 pellets in
individual subjects and averaged 61 pellets during the control
period, a value that did not change significantly when pellets of
different shapes were fed during the two subsequent 12-day
periods of bicarbonate administration. Ninety-five percent of
the steady-state intestinal pellet pool was reached in less than
six days. Figure lB shows cumulative pellet excretion in
relation to cumulative pellet administration. The slope of cu-
mulative pellet excretion after the fourth day in each study
phase was indistinguishable from cumulative pellet administra-
tion. More than 98% of the pellets were recovered. The
assignment of time to the fecal pools in the balance periods did
not differ when time was assigned based on total pellet recovery
divided by 30 or the actual elapsed time from the time of
passage of the last previous stool (before the first included in the
pool) until the time of passage of the last stool in the pool.
However, time based on pellets varied from 13% shorter to 12%
longer. Thus, pellet recovery was used to assign an estimate of
the time interval for each of the fecal pools in each subject.
Twenty-four-hour urines were collected daily. A two-hour
urine specimen was collected after overnight fasting and thirst-
ing at the end of the control period and during the latter part of
each of the two bicarbonate periods. Fasting blood specimens
were collected on four mornings in the control period and on
four mornings in each of the two bicarbonate periods. Duplicate
diets and feces were analyzed for calcium, phosphorus, mag-
nesium, sodium, potassium and chloride. Twenty-four-hour
urines were analyzed for creatinine, pH, total CO2 content,
ammonia, phosphate and calcium. Six-day urine pools were
prepared for the analysis of magnesium, sodium, potassium,
chloride, sulfate, organic acids, hydroxyproline and urea-ni-
trogen. Blood samples were analyzed for pH, total CO2 con-
tent, sodium, potassium, chloride, calcium, magnesium, phos-
phorus, creatinine and 1 ,25-(OH)2-D. 25-OH-D was measured
only among the six subjects fed the low Ca diet. These
analytical methods have been reported previously [17]. Serum
PTH was measured using kits obtained from Nichols Institute,
San Juan Capistrano, California, USA for the immunoradiomet-
nc assay of intact PTH [18]. The intra-assay coefficient of
variation for one normal subject with a mean serum PTH
concentration of 19 pg/mI averaged 10% (N = 4). The interassay
coefficient of variation for the same serum averaged 8% (N =
3). In 13 healthy subjects serum P1'H concentrations ranged
from 5 to 34 pg/ml and averaged 17 7 pg/mI. In paired studies
of five other healthy subjects serum PTH averaged 18 9 pg/mI
during control and fell to 5 2 pg/mI while the subjects were
taking calcitriol 0.5 g 6-hourly; P < 0.025, consistent with the
known effect of 1 ,25-(OH)2-D3 to suppress transcription of the
gene for pre-pro-PTH and secretion of PTH in vitro [19], Serum
PTH was undetectable in a patient with known idiopathic
hypoparathyroidism, and elevated, as expected, in two patients
with primary hyperparathyroidism (77 and 66 pg/mi) and a
patient with moderate renal failure associated with nephrocal-
cinosis, hypocalcemia and hypercalciuria (290 pg/mi).
Results are presented as group means SD or SEM.
Because the changes in response to NaHCO3 or KHCO3 were
similar regardless of dietary Ca intake or calcitriol administra-
tion, we have pooled the mean data for each subject to simplify
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Fig. 2. Mean daily fecal Ca excretion (lop panel), daily net intestinal
Ca absorption (second panel), daily urinary Ca excretion (third panel)
and daily Ca balance (bottom panel) for each of the 4 subjects fed a
normal Ca diet (I, U, A, •), the 3 subjects fed the low Ca diet (0, 0,
A) and the 3 subjects fed the low Ca diet and given calcitriol (+, x,
for the balance periods during control, during KHCO3 administration
and during NaHCO3 administration.
presentation of the results. We compared balance data during
the last six control days and the last six days of administration
of NaHCO3 and of KHCO3 by the paired i-test. The daily
urinary excretion of Ca during control, NaHCO3 and KHCO3
were compared by analysis of variance.
Results
Control conditions
The left side of the four panels of Figure 2 show the
components of the Ca balances for each subject during control.
The subjects who ate the normal Ca diets exhibited rates of
fecal Ca excretion averaging 16.7 2.6 mmol/day, and, with
serum calcitriol levels averaging 83 11 pmollliter, they
absorbed an average of 2.8 2.0 mmol Ca/day or 15 10% of
their dietary Ca. Their urinary Ca excretion rates averaged 3.9
1.9 mmol/day and Ca balances averaged —1.1 2.4 mmol/
day.
The three subjects who ate the low Ca diet alone exhibited
fecal Ca excretion rates averaging 4.7 1.3 mmol/day, a value
lower, as expected, than among the subjects who ate the normal
Ca diet (P < 0.001). Their serum calcitriol levels averaged 79
11 pmol/liter and they absorbed 0.1 0.8 mmol Ca/day or 3
18% of their dietary Ca. Net intestinal Ca absorption for these
three subjects was significantly less than that observed both for
the four subjects who ate the normal Ca diet and for the three
subjects who ate the low Ca diet and were also given calcitriol
(P < 0.025). Their urinary Ca excretion averaged 3.5 1.5
mmol/day and their Ca balances averaged —3.3 0.8 mmol/
day.
The three subjects who ate the low Ca diet and were also
given calcitriol exhibited fecal Ca excretion rates averaging 2.3
0.3 mmollday. Their serum calcitriol levels averaged 184 11
pmollliter and they absorbed on the average 3.3 0.6 mmol Ca/
day or 58 7% of their dietary Ca. Their urinary Ca excretion
averaged 6.3 1.7 mmollday and their Ca balances averaged
—3.0 1.1 mmollday.
Serum PTH concentrations for these subjects given calcitriol
averaged 10 7 pg/mI, a value that tended to be lower than the
mean value of 21 14 pg/ml for the three subjects who ate the
low Ca diet alone and the mean value of 21 6 pg/mI for the
four subjects who ate the normal Ca diet.
There were no other differences between the three groups
with respect to blood, urine or fecal composition or balances.
As shown in Table 1, blood composition during control for all
ten subjects was normal. As shown in Table 2, body weight was
stable and fecal weight was normal during the control period.
Calcium balances were, on the average for all ten subjects,
significantly negative averaging —2.3 1.9 mmol/day P < 0.005
versus zero; (Table 2). By contrast, balances of magnesium,
phosphorus, sodium, potassium and chloride were positive,
consistent with unmeasured losses (Table 2). Table 3 shows the
blood acid-base measurements and the components of acid
balance. Blood [H] and [HC03] were normal. Acid balances
averaged —10 11 mEq/day, slightly, but significantly, less
than zero (P = 0.01). Fasting urine composition (Table 4), as
well as urine volume and urinary excretion of creatinine,
hydroxyproline, urea-nitrogen, oxalate and citrate were normal
(Table 5).
Effects of NaHCO3
The administration of NaHCO3, 60 mEq/day, had no effect on
fecal Na excretion (Table 2) or fecal unmeasured anion excre-
tion (Table 3); thus all of the administered NaHCO3 was
absorbed. This daily dose of NaHCO3 had no detectable effect
to lower blood [H] or raise serum [HC03] when measured
twelve hours after the last dose (Table 1). Serum 1 ,25-(OH)2-D
levels and serum PTH levels also did not change (Table I).
Urine volume increased slightly (Table 5), probably related in
part to the 90 mI/day volume of NaHCO3 solution and rinses
administered. Body weight (Table 2), fecal weight (Table 2) and
urinary creatinine excretion (Table 5) did not change from
control.
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Table 1. Blood composition
Control NaHCO1 P KHCO3 P
Total Ca mmol/liter 2.38 0.lOa 2.36 0.10 —0.02 0.04 NS 2.37 0.12 —0.01 0.04 NS
Total Mg 0.92 0.04 0.92 0.04 0 0.03 NS 0.92 0.04 0 0.02 NS
mmol/liter
P04 mmol/liter 1,40 0.10 1.42 0.15 +0.02 0.05 NS 1.47 0.15 +0.07 0.06 <0.01
Na mmoi/iiier 142 I 142 1 0 1 NS 142 1 0 I NS
K inmol/liter 4.1 0.3 4.0 0,2 —0.1 0.3 NS 4.1 0.1 0 0.2 NS
Cl mmoi/liter 105 3 105 3 0 2 NS 104 3 —l I NS
Creatinine 108 8 108 9 0 3 NS 108 8 0 4 NS
iunol/!iler
l,25-(OH)2-D 112 51 104 34 —8 22 NS 98 33 —14 22 NS
pmol/iiter
250HDL 32 8 28 7 —4 8 NS 31 5 —1 8 NS
nmol/liter
iPTH pg/mi 18 10 18 11 0 5 NS 18 II 0 3 NS
a Variance shown as SD throughout table
b Measured only for the three subjects fed a low Ca diet and for the three subjects given calcitriol
Table 2. Mineral balances
Control NaHCO3 P KHCO3 P
Initial weight 68.58 8.89 68.63 8.95 68.89 8.71
Final weight 68.49 8.87 68.69 9.04 69.10 8.69
Fecal weight glday 142 28 140 46 —2 34 NS 133 24 9 14 NS
Calcium, mmol/day
Diet 10.9 7.4 10.9 7.4 0 NS 10.9 7.4 0 NS
Feces 8.8 7.0 8.8 7.1 0 1.0 NS 8.8 7,0 0 1.0 NS
Net intestinal absorption 2.1 1.9 2.1 2.0 0 1.0 NS 2.1 1.7 0 1.0 NS
Urine 4.4 2.0 4.2 2.0 —0.2 0.3 NS 3.5 1.9 —0.9 0.7 <0.005
Balance —2.3 1.9 —2.1 2.4 +0.2 1.1 NS —1.4 1.8 +0.9 0.9 =0.01
Magnesium mmo!/day
Diet 18.3 3.1 18.3 3.1 0 NS 18.3 3.1 0 NS
Feces 12.4 3.4 11.8 3.5 —0.6 0.8 <0.025 11.9 3.6 —0.5 1.5 NS
Net intestinal absorption 5.9 3.1 6.5 3.2 +0.6 0.8 <0.025 6.4 3.6 +0.5 1.5 NS
Urine 5,4 1.5 5.3 1.4 —0.1 0.6 NS 4.4 1.2 —1.0 0.7 <0.005
Balance +0.5 2.6 +1.2 2.7 +0.7 0.9 <0.05 +2.0 3.4 +1.5 1.7 <0.025
Phosphorus mmol/day
Diet 54.3 9.1 54.3 9.1 0 NS 54.3 9.1 0 NS
Feces 17.5 5.5 16.6 6.0 —0.9 1.5 NS 17.4 5.5 —0.1 1.6 NS
Net intestinal absorption 36.8 6.5 37.7 7.1 +0.9 1.5 NS 36.9 7.0 +0.1 1.6 NS
Urine 30.6 3.7 30.0 5.7 —0.6 2.4 NS 28.5 4.5 —2.1 1.8 <0.005
Balance +6.2 3.5 +7.7 4.1 +1.5 2.6 NS +8.4 4.6 +2.3 2.9 <0.05
Sodium
Diet 154 16 214 15 +60 1 <0.001 154 16 0 NS
Feces 3±2 3±2 0±2 NS 2±1 —1±1 NS
Net intestinal absorption 151 16 211 16 +60 2 <0.001 152 16 +1 1 NS
Urine 140 22 189 21 +49 16 <0.001 139 21 —l 15 NS
Balance +11 19 +22 19 +11 15 <0.05 +13 16 +2 14 NS
Potassium
Diet 84 11 84 11 0 NS 145 II +61 2 <0.001
Feces 15±3 13±4 —2±4 NS 15±3 0±2 NS
Net intestinal absorption 69 10 71 9 +2 4 NS 130 10 +61 2 <0.001
Urine 62 12 63 11 +1 6 NS 112 16 +50 10 <0.001
Balance +7 6 +8 9 +1 5 NS +18 14 +11 10 <0.01
Chloride
Diet 141 14 141 14 0 NS 141 14 0 NS
Feces 1±1 1±1 0±1 NS 1±1 0±1 NS
Net intestinal absorption 140 14 140 14 0 I NS 140 14 0 I NS
Urine 133 23 134 15 +1 15 NS 130 21 —3 13 NS
Balance +7 17 +6 10 —l 15 NS +10 17 +3 13 NS
Variance shown as SD throughout table
NaHCO3 administration had no significant effect on fasting
serum total calcium concentration (Table 1). Average daily
urinary Ca excretion evaluated by nested analysis of variance,
did not change during NaHCO3 administration (Fig. 3). The
components of calcium balance (Fig. 2, Table 2), fasting UaV/
GFR (Table 4) and urinary hydroxyproline excretion (Table 5)
also were unchanged during NaHCO3 administration.
NaHCO3 administration was accompanied by small but sig-
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Table 3. Blood acid-base measurements and the components of acid balance
Control NaHCO3 P KHCO3 P
Blood [H] 39.7 2.0 39.7 1.7 0 1.1 NS 39.8 1.5 +0.1 2.2 NS
nEqiliter
pH 7.40 7.40 7.40
Serum [HCO3] 27.2 0.8 27.5 1.3 +0.3 0.9 NS 27.3 1.1 +0.1 0.3 NS
mEq/!iter
pCO2mmHg 45±3 46±4 +1±2 NS 45±2 0±3 NS
Diet unmeasured 57 11 57 Ii 0 NS 57 11 0 NS
anion
Fecal unmeasured 28 7 27 S — I 6 NS 26 5 —2 3 NS
anion
UrineSO4 39±7 37±6 —2±2 NS 37±6 —2±3 NS
Urine organic anion 35 6 38 9 +3 5 NS 38 7 +3 4 NS
Endogenous acid 45 10 45 14 0 8 NS 44 12 —l 6 NS
prod.
Bicarbonate fed 0 60 1 60 I <0.001 61 2 61 2 <0.001
Total acid 45 10 —15 14 —60 11 <0.001 —17 13 —62 6 <0.001
production
Urine LW] 1030 290 220 100 —810 240 <0.001 230 90 —800 250 <0.001
nEqiliter
pH 5.99 6.66 6.65
NH4+ mEq/day 37 5 20 5 —17 2 <0.001 19 5 —18 4 <0.001
Titratable
acid mEq/day 22 4 10 5 —12 3 <0.001 10 4 —11 2 <0.001
HC03 mEqiday 4 2 24 7 +20 6 <0.001 23 8 +20 7 <0.001
Renal net
acid excretion 55 9 6 13 —49 9 <0.001 6 13 49 10 <0.001
Acid balance —10 11 —21 21 —11 15 <0.05 —23 15 —13 12 <0.01
Table 4. Fasting urine composition
Control NaHCO3 P KHCO3 P
Ua V/GFR 0.0268 0,0175 0.0220 0.0181 —0.0048 0.0079 NS 0.0165 0.0154 —0.0103 0.0079 <0.005
mmol/liter
UM9 V/GFR
mmol/liter
0.038l 0.0186 0.0330 0.0138 —0.0051 0.0120 NS 0.0319 0.0101 —0.0062 0.0136 NS
U4 V/GFR
mmol/liter
0,141 0.061 0.189 0.090 +0.048 0.066 =0.05 0.149 0.057 +0.008 0.028 NS
% ElF P04 10.0 4,1 12.6 4.6 +2.6 3.2 <0.05 10.5 4.0 +0.5 2.2 NS
UNa V/GFR 0.552 0.345 0.697 0.410 +0. 145 0.276 NS 0.402 0.275 0.150 0.207 0.05
mmol/liter
% E/F Na 0.39 0.24 0.49 0.29 +0.10 0.20 NS 0.28 0.19 —0.11 0.15 =0.05
U1 V/GFR 0.637 0.421 0.590 0.310 —0.047 0.245 NS 0.443 0.291 —0.195 0.22 <0.05
mmo!Iliter
% ElF Cl 0.61 0.41 0.56 0.30 —0.05 0.24 NS 0.43 0.28 —0,18 0.25 =0.05
UK V/GFR 0.280 0.121 0.294 0.178 +0.014 0.146 NS 0.308 0.129 +0.027 0.092 NS
mmollliter
UNet acid V/GFR 0.313 0.155 0.246 0.123 0.067 0.162 NS 0.268 0.122 0.045 0.114 NS
mEqiliter
nificant decreases in fecal magnesium excretion averaging —0.6
0.8 mmol/day; P < 0.025 and thus an equivalent increase in
net intestinal magnesium absorption and magnesium balance
(Table 2).
Sodium balances were more positive, averaging + 11 15
mEq/day above control (P < 0.05), because urinary Na excre-
tion increased by only + 49 16 mEq/day, an average of 82%
of the additional Na fed/day (Table 2). Renal net acid excretion
also declined by an average of only —49 9 mEq/day (Table 3)
so that similarly, on the average, only 82% of the 60 mEq HCO3
fed per day was recovered. Thus, acid balances became signif-
icantly more negative by —11 15 mEq/day (P < 0.05; Table
3).
Phosphate, potassium and chloride balances were not af-
fected by NaHCO3 (Table 2). Fasting U04 V/GFR increased
slightly but significantly (Table 4). Urinary citrate excretion
increased (Table 5), as expected, as urine pH rose and net acid
excretion fell [121 (Table 3). Urinary oxalate excretion also
increased significantly (Table 5).
Effects of KHCO3
The administration of KHCO3, 61 mEq/day, had no effect on
fecal K excretion (Table 2) or fecal unmeasured anion excretion
(Table 3); thus all of the administration KHCO3 was absorbed.
Serum [K], blood [H], serum [HC03], serum 1,25-(OH)2-D
and serum PTH concentrations also did not change from control
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Table 5. Urinary volume and excretion rates of creatinine, hydroxyproline, urea-nitrogen, oxalate and citrate
Control NaHCO3
—
P KHCO3 i P
Urine volume 1630 550 1910 870 +280 370 <0.05 1850 700 +220 290 <0.05
mi/day
Creatinine 17.9 2.6 18.3 2.7 +0.4 0.7 NS 18.0 2.6 +0.1 0.6 NS
mmoi/day
Hydroxyproline 0.37 0.07 0.38 0.08 +0.01 0.04 NS 0.37 0.07 0 0.02 NS
mmol/day
Urea-N g/day 10.9 1.7 10.6 1.7 —0,3 1.1 NS 10.5 1.8 —0.4 0.8 NS
Oxalate 0.46 0.22 0.62 0.30 +0.16 0.12 <0.005 0.56 0.30 +0.10 0.13 =0.05
mmoi/day
Citrate 3.6 1.2 4.7 1.5 +1.1 1.0 <0.01 5.0 1.3 +1.4 0.8 <0.001
mmoi/day
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Fig. 3. Mean daily urinary Ca excretion for all ten subjects during
control, during KHCO3 and during NaHCO3 administration SEM.
KHCO3 administration was accompanied by a significant decline in
urinary Ca excretion compared both to control and to NaHCO
administration, as evaluated by nested analysis of variance, regardless
of dietary Ca intake or the administration of calcitriol; P < 0.001.
(Table 1). Body weight and fecal weight (Table 2) and urinary
creatinine excretion (Table 5) did not change. Daily urine
volume increased slightly but significantly, again likely in part
due to the 90 mI/day of KHCO3 solution and rinses adminis-
tered.
KHCO3 administration had no effect on fasting serum total
calcium (Table I). However, urinary calcium excretion fell
significantly throughout the 12 day period of KHCO3 adminis-
tration, as evaluated by nested analysis of variance (Fig. 3).
During the 6-day balance period urinary Ca excretion declined
by an average of —0.9 0.7 mmollday (P < 0.005), so that in
the absence of changes in fecal calcium excretion (Fig. 2)
calcium balances became equivalently less negative by +0.9
0.9 mmol/day (P = 0.01; Table 2). The magnitude of the changes
from control in urinary Ca excretion during KHC03 were
similar regardless of dietary Ca intake or the administration of
calcitriol, averaging — 1.1 0.8 mmol/day for the four subjects
who ate the normal Ca diet, —0.7 0.4 mmol/day for the three
subjects who ate the low Ca diet alone and —0.8 1.2 mmoll
day for the three subjects who ate the low Ca diet and were
given calcitriol. By analysis of variance for repetitive measure-
ments, these changes were different from control for each group
(P < 0.05) but not different between groups. The changes from
control in Ca balance during KHCO3 were also similar, aver-
aging + 1.0 1.0 mmoLlday for the four subjects who ate the
normal Ca diet, +0.6 0.6 mmollday for the three subjects who
ate the low Ca diet alone and + 1.0 1.1 for the three subjects
also given calcitriol. None of these changes were significant
because of the small numbers in each group. Fasting UaV/
GFR also fell significantly (Table 4). Urinary hydroxyproline
excretion did not change during KHCO3 administration (Table
5).
Fasting serum P04 rose slightly but significantly during
KHCO3 administration (Table 1). Urinary P04 excretion fell
slightly but significantly during KHCO3 by —2.1 1.8 mmoll
day (P <0.005), so that P04 balances became more positive by
+2.3 2.4 mmol/day; P < 0.05 (Table 2). KHCO3 administra-
tion was accompanied by a small and insignificant decline in
fecal magnesium excretion and a significant fall in urinary
magnesium excretion, averaging —1.0 0.7 mmol/day (P <
0.005). Thus, magnesium balances became more positive, the
increments averaging +1.5 1.7 mmol/day (P <0.025; Table
2).
Potassium balances were more positive averaging +11 10
mEq/day above control (P <0.01)because urinary K excretion
increased by only + 50 10 mmol/day, a average of 82% of the
additional K fed/day (Table 2). Renal net acid excretion fell by
only —49 10 mEq/day so that, similarly, only an average of
80% of the bicarbonate administered was recovered (Table 3).
Thus, acid balances became more negative by —13 12 mEq/
day (P < 0.01; Table 3). KHCO3 had no effect on Na or Cl
balances or the components of these balances. However, fast-
ing UNaV/GFR and U1V/GFR were significantly lower than
control during KHCO3 administration (Table 4). Urinary citrate
excretion rose during KHCO3 (Table 5), as expected in the face
of a more alkaline urine and a fall in renal net acid excretion
(Table 3). Urinary oxalate excretion increased significantly
(Table 5).
Discussion
Sakhaee and associates demonstrated that the administration
of potassium citrate, 60 mmollday, but not equivalent quantities
of sodium citrate, reduced urinary Ca excretion in patients with
Control KHCO3 NaHCO3
I. I .1. .1.1.1
694 Lemann et a!: KHCO3 reduces urinary calcium excretion
uric acid nephrolithiasis [12]. The present studies demonstrate
that equivalent amounts of alkali, administered as KHCO3, but
not NaHCO3, also reduce urinary Ca excretion in healthy
subjects regardless of dietary Ca intake or prevailing serum
1 ,25-(OH)2-D concentrations and probably serum PTH concen-
trations. Moreover, the effect of KHCO3 to reduce urinary Ca
excretion appeared to be prolonged since fasting urinary Ca/
GFR was lower during KHCO3 than during control (Table 5).
Calcium retention during KHCO3 administration occurred with-
out a detectable change in net intestinal Ca absorption (Table
2). Thus, the administration of alkali, like the administration of
acid as NH4CI [7] or increased dietary protein [11], does not
appear to alter intestinal Ca absorption. Ca retention during
KHCO3 administration, therefore, must have been the result of
renal Ca retention or, since serum Ca concentrations did not
change, enhanced Ca retention in bone or both.
The failure of NaHCO3, 60 mmol/day, to reduce urinary Ca
excretion is perhaps surprising in light of prior observations
showing that: a) NaHCO3, 70 mmol/day, nearly abolished the
increase in urinary Ca excretion that occurred when dietary
protein intake was increased and fixed acid production rose
UI]; b) acute NaHCO3 administration to both normal and
acidotic volume-expanded dogs reduced urinary Ca excretion
independent of PTH [20]; and c) in a review of previous studies
of our own [7], NaHCO3 in an average dose of 120 mmol/day
reduced urinary Ca by an average of —1.7 mmollday. On the
other hand, some other balance studies have failed to demon-
strate an effect of NaHCO3 to reduce urinary Ca excretion [21].
Since the natriuresis of volume expansion with NaCI is well
known to be accompanied by calciuresis [22], it has been
proposed that the failure of NaHCO3 to reduce urinary Ca
excretion may be a consequence of the accompanying natriure-
sis [12, 23]. Our data are consistent with such an opposing effect
of Na to override the effect of HCO3 to reduce urinary Ca
excretion since urinary Ca excretion did not change from
control during NaHCO3 either on a 24 hour basis when urinary
Na excretion rose and net acid excretion fell (Tables 2 and 3) or
during fasting when UNaV/GFR and U,, acid V/GFR did not
change from control (Table 4).
On the other hand, it appears reasonable to consider the
possibility that K, independent of HCO3, may act to reduce
urinary Ca excretion. Serum total Ca and creatinine concentra-
tions (Table I), urinary creatinine excretion rates (Table 5) and
body weight (Table 2) did not change during KHCO3, so that it
is unlikely that a fall in glomerular filtration of Ca accounted for
the decline in the urinary Ca excretion. KHCO3 administration
may thus have stimulated renal tubular Ca reabsorption. Spec-
ulatively, intermittently higher serum K levels during KHCO3
administration might enhance tubular K entry in the ascending
loop of Henle, thereby creating a more positive luminal voltage
[24, 25], thus enhancing tubular Ca as well as Mg reabsorption
(Table 2, Fig. 3).
Administration of both NaHCO3 and KHCO3 were accom-
panied by equivalently more positive Na or K balances, respec-
tively (Table 2), and equivalently more negative acid balances
(Table 3), the latter being equivalent to HCO3 retention. Since
a) chronic metabolic acidosis is accompanied by a loss of bone
carbonate while chronic metabolic alkalosis is accompanied by
a gain of bone carbonate [8] and b) acute metabolic acidosis is
accompanied by a loss of Na and K from bone surfaces [261, it
seems reasonable to suggest that administration of either
NaHCO1 or KHCO3 resulted in deposition of these salts (or
their equivalent as carbonates) in bone to an equal degree.
However, KHCO3 administration was accompanied by sig-
nificantly more positive Ca, P04 and Mg balances suggesting, in
addition, net deposition of mineral in the skeleton. Neither
KHCO1 or NaHCO3 administration was accompanied by a
detectable decline in urinary hydroxyproline excretion as evi-
dence of reduced bone resorption. However, based on our prior
observations of the relationship between urinary hydroxy-
proline excretion and Ca balance [13], a detectable fall in
urinary hydroxyproline excretion would not have been ex-
pected in the face of less negative Ca balances averaging only +
0.9 mmol/day. Thus, inhibition of bone resorption cannot be
excluded. Alternatively, KHCO3 administration may have
acted to stimulate bone formation, a possibility we did not
evaluate. Regardless of the mechanism, the effect of KFICO3 to
promote Ca retention was independent of experimental varia-
tions in dietary Ca intake and of experimental variations in
serum 1 ,25-(OH)2-D concentrations. Moreover, serum PTH
concentrations did not change in response to KHCO3 among
subjects fed the low Ca diet alone or those who were also given
calcitriol. Thus, the effects of KHCO3 to promote Ca retention
does not appear to be mediated by variations in secretion rates
or blood levels of either 1 ,25-(OH)2-D3 or PTH.
The present studies appear to have potential clinical signifi-
cance when taken together with previous studies showing that
metabolic acidosis [2], high protein diets [11] and animal as
opposed to cereal and vegetable proteins [27] increased urinary
Ca excretion. Our data provide further evidence in support of
the view that ingestion of diets containing more vegetables and
fruits, naturally containing actual or potential KHCO3 and less
protein, especially of animal origin, would enhance Ca retention
and protect skeletal mass. In addition, since most dietary Na is
NaCI, not NaHCO3, the present studies provide further indirect
support for the view that a lower dietary NaCI content would
minimize urinary Ca excretion and protect bone.
The mechanism for the increase in urinary oxalate excretion
rates during both NaHCO3 and KHCO3 administration is not
clear. Since the urines were not collected into acid, it is possible
that in vitro conversion of ascorbate to oxalate in relatively
alkaline urine was responsible [28]. Alternatively and specula-
tively, bicarbonate administration may enhance intestinal oxa-
late absorption or endogenous oxalate synthesis.
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